Sales & Marketing The B2C prescription: Marketing lessons for B2B pharma compa... B2B is often seen to lag behind B2C in marketing, and nowhere is that more true than in the pharmaceuticals industry.
News GSK's Walmsley could sell off sports products - reports GlaxoSmithKline’s new CEO Emma Walmsley is set to outline her vision for the company alongside half-year results next month – but reports suggest that she may shake up the consumer products
News Zymeworks cuts deal to buy Theravance for $929m in cash Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.